{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T21:52:49Z","timestamp":1725054769859},"reference-count":52,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:p>O hipertireoidismo da doen\u00e7a de Graves, a forma mais comum de hipertireoidismo, \u00e9 diretamente causado por auto-anticorpos que ativam o receptor do TSH. A etiologia parece ser multifatorial, envolvendo fatores gen\u00e9ticos e n\u00e3o gen\u00e9ticos. As op\u00e7\u00f5es terap\u00eauticas atualmente dispon\u00edveis s\u00e3o as drogas antitireoidianas (DAT), a cirurgia e o iodo radioativo (131I), sendo que nenhuma delas \u00e9 considerada ideal, visto que n\u00e3o atuam diretamente na etiologia\/patog\u00eanese da disfun\u00e7\u00e3o. O 131I tem sido cada vez mais utilizado como primeira escolha terap\u00eautica por tratar-se de um tratamento definitivo, de f\u00e1cil administra\u00e7\u00e3o e seguro. A associa\u00e7\u00e3o com DAT, fatores progn\u00f3sticos de fal\u00eancia e o c\u00e1lculo da dose administrada s\u00e3o alguns dos aspectos controversos na utiliza\u00e7\u00e3o do 131I, sendo este o principal foco desta revis\u00e3o. As DAT ainda s\u00e3o utilizadas como primeira escolha nos casos de pacientes com b\u00f3cios pequenos, crian\u00e7as e adolescentes, e na gravidez. A tireoidectomia \u00e9, atualmente, quase um tratamento de exce\u00e7\u00e3o, com indica\u00e7\u00e3o restrita para casos em que as DAT ou o 131I sejam contra-indicados.<\/jats:p>","DOI":"10.1590\/s0004-27302004000100017","type":"journal-article","created":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T20:03:22Z","timestamp":1115928202000},"page":"159-165","source":"Crossref","is-referenced-by-count":3,"title":["Iodo radioativo no manejo do hipertireoidismo da doen\u00e7a de Graves"],"prefix":"10.1590","volume":"48","author":[{"given":"V\u00e2nia A.","family":"Andrade","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Luiz","family":"Gross","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luiza","family":"Maia","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper DS","year":"2003","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Wickham Survey","volume":"7","author":"Tunbridge WMG","year":"1977","journal-title":"Clin Endocrinol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim","volume":"111","author":"Chen CR","year":"2003","journal-title":"J Clin Invest","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0889-8529(05)70295-4","article-title":"Clinical and laboratory diagnosis of thyrotoxicosis","volume":"27","author":"Dabon-Almirante CL","year":"1998","journal-title":"Endocrinol Metab Clin North Am","ISSN":"http:\/\/id.crossref.org\/issn\/0889-8529","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein I","year":"2001","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/01.CIR.87.5.1435","article-title":"The thyroid and the heart","volume":"87","author":"Polikar R","year":"1993","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1996.tb02068.x","article-title":"Cardiomyopathy associated with Graves' disease","volume":"45","author":"Koshiyama H","year":"1996","journal-title":"Clin Endocrinol"},{"key":"ref8","first-page":"54","article-title":"Hipertireoidismo com fibrila\u00e7\u00e3o atrial: \u00e9 necess\u00e1rio anticoagular todos os pacientes?","volume":"40","author":"Gross JL","year":"1996","journal-title":"Arq Bras Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2265.1994.tb02572.x","article-title":"Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis","volume":"41","author":"Franklin J","year":"1994","journal-title":"Clin Endocrinol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women","volume":"332","author":"Cummings SR","year":"1995","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","article-title":"Mortality after the treatment of hyperthyroidism with radioactive iodine","volume":"338","author":"Franklyn JA","year":"1998","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.1995.03520340064038","article-title":"Treatment guidelines for patients with hyperthyroidism and hypothyroidism","volume":"273","author":"Singer PA","year":"1995","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/jcem-70-6-1518","article-title":"Current trends in the management of Graves' disease","volume":"70","author":"Solomon B","year":"1990","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States","volume":"1","author":"Wartofsky L","year":"1991","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1997.7.225","article-title":"Case selection and restrictions recommended to patients with hyperthyroidism in South America","volume":"7","author":"Romaldini JH","year":"1997","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/thy.1997.7.259","article-title":"Radioiodine and the immune system","volume":"7","author":"DeGroot LJ","year":"1997","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1997.d01-1737.x","article-title":"The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis","volume":"46","author":"Aizawa Y","year":"1997","journal-title":"Clin Endocrinol"},{"key":"ref18","first-page":"147","article-title":"Estudo da rela\u00e7\u00e3o custo\/efetividade no tratamento da doen\u00e7a de Basedow-Graves","volume":"32","author":"Ward LS","year":"1986","journal-title":"Rev Ass Med Brasil"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-105-6-900","article-title":"Radioiodine treatment for Graves' disease: An assessment of its potential risks","volume":"105","author":"Graham GD","year":"1986","journal-title":"Ann Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199803123381103","article-title":"Mortality after the treatment of hyperthyroidism with radioactive iodine","volume":"338","author":"Franklyn JA","year":"1998","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM198408163110702","article-title":"Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease","volume":"311","author":"Sridama V","year":"1984","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref22","first-page":"40","article-title":"Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage","volume":"83","author":"Chiovato L","year":"1998","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF03348615","article-title":"A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism","volume":"13","author":"Marcocci C","year":"1990","journal-title":"J Endocrinol Invest","ISSN":"http:\/\/id.crossref.org\/issn\/0391-4097","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.1995.5.243","article-title":"Treatment with propyltiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease","volume":"5","author":"Tuttle RM","year":"1995","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2265.1997.2741075.x","article-title":"The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease","volume":"47","author":"Hancock L","year":"1997","journal-title":"Clin Endocrinol"},{"key":"ref26","first-page":"1229","article-title":"Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication","volume":"84","author":"Sabri O","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(88)91950-2","article-title":"Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered","author":"Velkeniers B","year":"1988","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref28","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia A","year":"2000","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref29","first-page":"3488","article-title":"Effect of methimazole on the efficacy of radioiodine therapy in Graves' hyperthyroidism","volume":"86","author":"Andrade VA","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM198408163110702","article-title":"Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease","volume":"311","author":"Sridama V","year":"1984","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","article-title":"A randomized comparison of radioiodine doses in Graves' hyperthyroidism","volume":"88","author":"Leslie WD","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1995.tb02039.x","article-title":"Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?","volume":"43","author":"Jarlov AE","year":"1995","journal-title":"Clin Endocrinol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2000.01020.x","article-title":"Anti-thyroid drug treatment before radioiodine in patients with Graves' disease: soother or menace?","volume":"53","author":"Perros P","year":"2000","journal-title":"Clin Endocrinol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(83)91217-2","article-title":"Radioiodine-induced thyroid storm: Case report and literature review","volume":"75","author":"McDermott MT","year":"1983","journal-title":"Am J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(75)90117-8","article-title":"Acute changes in thyroid function in patients treated with radioactive iodine","volume":"2","author":"Shafer RB","year":"1975","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref36","first-page":"231","article-title":"Intentional radioiodine ablation in Graves' disease","author":"Wise PH","year":"1975","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-121-8-199410150-00001","article-title":"Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves' disease","volume":"121","author":"Burch HB","year":"1994","journal-title":"Ann Inter Med"},{"key":"ref38","first-page":"387","article-title":"Thyroid hormone concentrations after radioiodine therapy for hyperthyroidism","volume":"20","author":"Tamagna EI","year":"1979","journal-title":"J Nucl Med","ISSN":"http:\/\/id.crossref.org\/issn\/0161-5505","issn-type":"print"},{"key":"ref39","first-page":"4012","article-title":"Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism","volume":"84","author":"Andrade VA","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2002-020580","article-title":"Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease","volume":"87","author":"Bogazzi F","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bmj.288.6416.518","article-title":"Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression","volume":"288","author":"Weetman AP","year":"1984","journal-title":"Br Med J","ISSN":"http:\/\/id.crossref.org\/issn\/0007-1447","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF03348615","article-title":"A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism","volume":"13","author":"Marcocci C","year":"1990","journal-title":"J Endocrinol Invest","ISSN":"http:\/\/id.crossref.org\/issn\/0391-4097","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.1995.5.243","article-title":"Treatment with propyltiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease","volume":"5","author":"Tuttle RM","year":"1995","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2265.1997.2741075.x","article-title":"The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease","volume":"47","author":"Hancock L","year":"1997","journal-title":"Clin Endocrinol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jcem.83.2.4538","article-title":"Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism","volume":"83","author":"Imseis RE","year":"1998","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref46","first-page":"1229","article-title":"Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication","volume":"84","author":"Sabri O","year":"1999","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(88)91950-2","article-title":"Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered","author":"Velkeniers B","year":"1988","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism","volume":"321","author":"Bartalena L","year":"1989","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/thy.1998.8.49","article-title":"Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism","volume":"8","author":"Manso PG","year":"1998","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"key":"ref50","first-page":"339","article-title":"Radiation and Graves' ophthalmopathy","volume":"80","author":"DeGroot LJ","year":"1995","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1470001","article-title":"Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres","volume":"147","author":"Bonnema SJ","year":"2002","journal-title":"Eur J Endocrinol","ISSN":"http:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartalena L","year":"1998","journal-title":"N Engl J Med","ISSN":"http:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v48n1\/19529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T01:38:42Z","timestamp":1495676322000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302004000100017&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0004-27302004000100017"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302004000100017","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}